Skip to main content

MoneyWorks4Me

Kabra Drugs informs about board meeting

22 Dec 2025 Evaluate

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Kabra Drugs has informed that a meeting of the Board of Directors of is scheduled to be held on Thursday 1 January 2026, at the Corporate office at Chennai of the Company, inter alia, to consider and approve the following strategic business items: 1. Change of Name of the Company 2. Strategic Acquisitions 3. Alteration of the Main Objects (MOA) 4. Any other agenda with the permission of the chair.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..